US Stock MarketDetailed Quotes
CSPHF CSTONE PHARMACEUTICALS
- 0.120000
- 0.0000000.00%
15min DelayTrading May 2 16:00 ET
153.04MMarket Cap-3000P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.120000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)1.28BShares0.47000052wk High2.40P/B153.04MFloat Cap0.11940052wk Low--Dividend TTM1.28BShs Float2.500000Historical High--Div YieldTTM0.00%Amplitude0.119400Historical Low--Avg Price1Lot Size
CSTONE PHARMACEUTICALS Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (Q4)Dec 31, 2018 | (Q3)Sep 30, 2018 | (FY)Dec 31, 2017 | (Q4)Dec 31, 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Net income from continuing operations | 59.32%-367.23M | 52.99%-902.68M | -57.26%-1.92B | 47.11%-1.22B | -28.74%-2.31B | -423.47%-1.79B | -813.76%-630.73M | ---- | -35.37%-342.55M | ---69.03M |
| Other non cash items | -1,194.90%-21.31M | 79.45%-1.65M | 65.61%-8.01M | 65.63%-23.29M | -740.61%-67.77M | -133.82%-8.06M | -399.82%-5.51M | ---- | -2,545.39%-3.45M | ---1.1M |
| Change In working capital | -293.83%-140.81M | 82.97%72.65M | -78.65%39.7M | -21.14%185.98M | 745.97%235.83M | 204.73%27.88M | 251.45%12.77M | ---- | -167.00%-26.62M | ---8.43M |
| -Change in receivables | -335.52%-95.31M | 134.41%40.47M | ---117.6M | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in inventory | -413.83%-95.46M | 135.30%30.42M | ---86.18M | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in prepaid assets | 1,002.57%105.2M | -113.17%-11.66M | 221.36%88.49M | 42.47%-72.91M | -215.39%-126.73M | -1,759.77%-40.18M | -199.40%-17.37M | ---- | 119.14%2.42M | --17.47M |
| -Change in other current assets | --68.85M | --0 | -725.93%-6.76M | -87.29%1.08M | 289.91%8.5M | --2.18M | --4.18M | ---- | --0 | ---- |
| -Change in other current liabilities | -115.13%-2.5M | 90.37%16.52M | --8.68M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 3.59%-588.84M | 58.85%-610.74M | -192.09%-1.48B | 52.99%-508.07M | -36.61%-1.08B | -229.37%-791.11M | -225.05%-162.31M | ---146.82M | -12.76%-240.19M | ---49.93M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Net PPE purchase and sale | --99K | --0 | -35.78%-91.03M | -589.21%-67.04M | -37.58%-9.73M | 42.47%-7.07M | 70.64%-2.64M | ---1.64M | -1,016.26%-12.29M | ---8.99M |
| Net intangibles purchase and sale | 248.86%151.57M | -75.22%-101.82M | -1,218.58%-58.11M | -528.67%-4.41M | 16.15%-701K | -274.89%-836K | ---148K | ---35K | -1,927.27%-223K | ---- |
| Net investment purchase and sale | -3.47%447.69M | 167.47%463.81M | -155.75%-687.48M | 279.74%1.23B | -81.29%-686.01M | -237.72%-378.41M | 37.80%127.25M | ---601.94M | 136.52%274.76M | --92.34M |
| Net other investing changes | ---- | -1,862.80%-6.54M | 109.93%371K | -124.79%-3.74M | -147.49%-1.66M | --3.5M | --1.5M | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 70.51%619.61M | 143.96%363.39M | -170.00%-826.55M | 279.20%1.18B | -74.45%-658.88M | -240.78%-377.7M | 48.75%127.05M | ---602.01M | 135.61%268.3M | --85.41M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Net issuance payments of debt | 12.82%91.43M | -9.46%81.04M | 57.03%89.51M | --57M | --0 | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | 13,416.17%341.82M | -84.97%2.53M | -98.74%16.83M | -39.06%1.34B | 60,504.50%2.2B | --3.63M | --2.88M | --748K | ---- | ---- |
| Net preferred stock issuance | ---- | ---- | ---- | ---- | ---- | --1.97B | --0 | --320.1M | --0 | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---307.22M | --0 | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,264.23%388.36M | -69.16%28.47M | -93.36%92.3M | -33.56%1.39B | 25.80%2.09B | 554,240.00%1.66B | --577K | --13.62M | -100.03%-300K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -24.78%558.68M | -75.44%742.72M | 168.51%3.02B | 60.61%1.13B | 741.03%701.34M | 40.06%83.39M | 1,358.89%734.35M | --1.41B | --59.54M | --50.34M |
| Current changes in cash | 291.48%419.12M | 90.13%-218.88M | -207.57%-2.22B | 486.28%2.06B | -28.74%351.73M | 1,674.69%493.61M | -197.77%-34.68M | ---735.21M | -36.83%27.81M | --35.48M |
| Effect of exchange rate changes | -45.84%18.87M | 154.83%34.84M | 61.24%-63.55M | -323.48%-163.98M | -40.99%73.37M | 3,237.37%124.33M | 169.19%1.68M | --59.36M | -125.55%-3.96M | ---2.42M |
| End cash Position | 78.40%996.67M | -24.78%558.68M | -75.44%742.72M | 168.51%3.02B | 60.61%1.13B | 741.03%701.34M | 741.03%701.34M | --734.35M | 40.06%83.39M | --83.39M |
| Free cash flow | 8.23%-653.89M | 56.37%-712.56M | -181.81%-1.63B | 46.89%-579.52M | -36.56%-1.09B | -216.19%-799.01M | -179.15%-165.09M | ---148.49M | -18.02%-252.7M | ---59.14M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg